原尚股份(603813.SH):擬在廣州市黃埔區設立合資公司新原科技
格隆匯3月24日丨原尚股份(603813.SH)公佈,公司與廣東新農人農業科技集團股份有限公司(簡稱“新農人”或“甲方”)近日於廣州市簽訂《戰略合作協議》,協議約定通過各自的資源優勢,共同構建廣州市黃埔區農產品穩產保供中心、粵港澳大灣區“菜籃子”集散中心(黃埔中心)以及廣州市黃埔區蛋品交易中心倉。具體內容詳見公司於2025年3月14日在上海證券交易所披露的《關於自願披露簽訂戰略合作協議的公吿》。為推進上述項目,雙方擬於廣州市黃埔區設立合資公司新原科技。新原科技註冊資本為1,000萬元,公司認繳出資400萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.